Christine Sacco - 24 May 2023 Form 4 Insider Report for Prestige Consumer Healthcare Inc. (PBH)

Role
Chief Financial Officer
Signature
/s/ Christine Sacco by William P'Pool as attorney-in-fact pursuant to power of attorney dated May 8, 2017 on file with the Commission
Issuer symbol
PBH
Transactions as of
24 May 2023
Net transactions value
-$1,468,319
Form type
4
Filing time
26 May 2023, 16:04:52 UTC
Previous filing
08 May 2023
Next filing
16 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBH Common Stock, par value $0.01 per share Options Exercise $633,089 +11,283 +25% $56.11 56,517 24 May 2023 Direct
transaction PBH Common Stock, par value $0.01 per share Sale $677,770 -11,283 -20% $60.07 45,234 24 May 2023 Direct F1
transaction PBH Common Stock, par value $0.01 per share Options Exercise $1,220,103 +25,746 +57% $47.39 70,980 24 May 2023 Direct
transaction PBH Common Stock, par value $0.01 per share Sale $1,546,562 -25,746 -36% $60.07 45,234 24 May 2023 Direct F1
transaction PBH Common Stock, par value $0.01 per share Sale $1,097,179 -18,265 -40% $60.07 26,969 24 May 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBH Employee Stock Options (rights to buy) Options Exercise $0 -11,283 -100% $0.000000* 0 24 May 2023 Common Stock 11,283 $56.11 Direct F2
transaction PBH Employee Stock Options (rights to buy) Options Exercise $0 -25,746 -100% $0.000000* 0 24 May 2023 Common Stock 25,746 $47.39 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $59.00 to $60.07.
F2 Options vested and became exercisable on the third anniversary of the grant date.